SENSEX NIFTY
73651.35 22123.65
655.04 (0.90%)
118.95 (0.54%)
 

NOTICES


Heading View
  SEBI Circular No. CIR/MRD/DP/01/2014 Dated 7th January, 2014   Click here
  SEBI Circular No. SEBI/HO/MIRSD/MIRSD2/CIR/P/2016/95, Dated 26th September, 2016.   Click here
DETACH
Increase
Minus
IPO Synopsis Earum Pharmaceuticals Ltd
Registered Office : G1 Ground Floor VR Complex,Nr Sanathal Cross Rd SP RingRd, Ahmedabad - 382210, Gujarat, India.
Phone : 91-79-48402525   Fax:
Email : cs@earumpharma.com
Website :www.earumpharma.com
Initial Public Offer of 18,48,000 equity shares of face value of Rs.10 each (the "equity shares") of Earum Pharmaceuticals Limited ("the company" or "epl" or "the issuer") at an issue price of Rs.36 per equity share for cash, aggregating up to Rs. 6.65 Crores ("public issue") out of which 96,000 equity shares of face value of Rs. 10 each, at an issue price of Rs. 36 per equity share for cash, aggregating Rs. 0.35 Crores will be reserved for subscription by the market maker to the issue (the "market maker reservation portion"). the public issue less market maker reservation portion i.e. issue of 17,52,000 equity shares of face value of Rs. 10 each, at an issue price of Rs. 36 per equity share for cash, aggregating upto Rs. 6.31 Crores is here in after referred to as the "net issue". the public issue and net issue will constitute 29.96% and 28.41 % respectively of the post issue paid-up equity share capital of the company. The face value of the equity share is Rs.10 each. Fixed Price issue at Rs.36 per share and is 3.6 times of the face value.  
Issue Money Payable On
Opens On Closes On Application Allotment
 21-Jun-19  26-Jun-19  36.00-0.00  0.00-0.00
Minimum Application for shares in Nos :  3000   Further Multiples of :  3000
  Rs Cr Lead Managers to the Issue
Project Cost  6.65 Hem Securities Ltd
Project Financed through Current Offer  6.65  
Post Issue Equity Share Capital  6.17  
Issue Price  36.00  
Projects
 To Meet Working Capital Requirements  General Corporate Purpose
Promoted By
 Bhumishth Narendrabhai Patel
 Payal Bhumishth Patel
Listing At
 BSE - SME
Registrar to the Issue
No Data available..!
 
Attention Investors: No need to issue cheques by investors while subscribing to IPO. just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. | Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.' "
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Clients: We are here with requesting you to submit your separate e-mail id to receive communications/reports, by submitting account modification form in this regards or if you have registered your family member e-mail id with us, please submit declaration in this regards. Further, if you have not registered e-mail id/mobile number with us, please register it by submitting account modification form which facilitates you to receive all the data/reports electronically. If you require any clarification, please feel free to call Mr. Hemant Shah on 9004603818 or email us at kyc@swcapital.in
Feedback | Back Office | Downloads | KYC | Disclaimer | Privacy Policy | Investor Grievances | Communique | Tariff Structure |
SCORES| Opening A Account| Filing A Complaints
Copyright © 2011 -SW Capital Pvt Ltd. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)